Pascale Augé

Before joining Inserm Transfert in 2014, Pascale had led Institut Pasteur’s Technology Transfer and Entrepreneurship office since 2011. She has more than 20 years’ experience in the fields of technological innovation in life science and health technology, research transfer and entrepreneurship, and the biotechnology startup industry. She headed business development at Neurotech, Entomed and AB Science then operational strategy in the sciences and health technology, and ran EY advisory biotech & life sciences activities in France. She also chaired the evaluation committee reviewing “high-market-potential products, technologies or services” at ANR from 2008 to 2011. She is Board of Directors' member of the pharmaceutical company, LFB SA, and is also member of Inserm Transfert Initiative Supervisory Board, ITI being the seed fund created by Inserm Transfert in 2005. Since 2017, she is VP of i-LAB national jury, the national competition for innovative companies from the Ministry of Research and innovation. She is an expert for the EIC (European Innovation Council) since 2019.

Pascale Augé holds a doctorate in molecular pharmacochemistry, experimental pharmacology and metabolism from Université Paris V, and a chemical engineering degree from the École de Chimie de Strasbourg.